The 7th Annual AI in Drug Discovery Conference, hosted by SAE Media Group, takes place 9-10 March 2026 at Hilton London ...

While the M&A emphasis is currently on life sciences, a business unit which sells products used in R&D and manufacturing ...

Researchers in the UK have started recruiting patients for a large-scale trial that will test a battery of Parkinson's ...

The filing of the legal action comes just a few days after J&J suffered a major setback in its defence in the US against ...

Debruyne has said that in recent years Bavarian Nordic has received several enquiries about a takeover but has never actively ...

There is an under-the-radar market access strategy that some manufacturers have implemented, but many others remain unaware ...

Back in June, pharmaphorum spoke with Entity Risk’s CEO and co-founder, Neal Masia, a leading health economist, about the unknowns unfolding in the US following the commencement of the second Trump ...

The two-year Resilience programme, set up with £4.5 million ($6 million) in government funding last year, uses new tools such ...

Moreover, innovations in LNP formulations have improved not only their targeting ability, but also their drug-loading ...

Interestingly, while only 16% of oncology researchers reported using AI in biomarker detection and assessment at the time of ...

Novo Nordisk has bolstered its pipeline by paying $340 million upfront for rights to an Omeros Corp drug with potential ...

Activist investor Shah Capital has called on the board of directors at Novavax to put the company up for sale, citing a ...